Clonal deletion of T lymphocytes against host organ by early post-transplant cyclophosphamide: clinical study of GVHD prophylaxis in HLA-haploidentical bone marrow transplantatio
Not Applicable
- Conditions
- Hematological malignancies and malignant solid tumors
- Registration Number
- JPRN-UMIN000009517
- Lead Sponsor
- Osaka medical center and research institute for maternal and child health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. Having a severe complication (NCI-CTCAE ver3.0 Grade II or more). 2. Having an uncontrolled infection. 3. Physician's decision.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method